Jul 12, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2018-N-4087-0004
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2018-N-4087: Proposed Current Good Manufacturing Practice Policies for Outsourcing Facilities: Considerations Regarding Access to Office Stock; Public Meeting; Request for Comments.